Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Changzhou Qianhong BiopharmaLTD Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Changzhou Qianhong BiopharmaLTD has a total shareholder equity of CN¥2.4B and total debt of CN¥22.0M, which brings its debt-to-equity ratio to 0.9%. Its total assets and total liabilities are CN¥2.6B and CN¥271.4M respectively. Changzhou Qianhong BiopharmaLTD's EBIT is CN¥225.7M making its interest coverage ratio -14.2. It has cash and short-term investments of CN¥661.4M.
Anahtar bilgiler
0.9%
Borç/özkaynak oranı
CN¥21.96m
Borç
| Faiz karşılama oranı | -14.2x |
| Nakit | CN¥661.40m |
| Eşitlik | CN¥2.36b |
| Toplam yükümlülükler | CN¥271.43m |
| Toplam varlıklar | CN¥2.63b |
Son finansal sağlık güncellemeleri
Here's Why Changzhou Qianhong BiopharmaLTD (SZSE:002550) Can Manage Its Debt Responsibly
Aug 21
Does Changzhou Qianhong BiopharmaLTD (SZSE:002550) Have A Healthy Balance Sheet?
Mar 24Recent updates
Here's Why Changzhou Qianhong BiopharmaLTD (SZSE:002550) Can Manage Its Debt Responsibly
Aug 21Changzhou Qianhong BiopharmaLTD (SZSE:002550) Has Affirmed Its Dividend Of CN¥0.12
May 26Changzhou Qianhong Biopharma CO.,LTD (SZSE:002550) Looks Just Right With A 26% Price Jump
May 21Investors Can Find Comfort In Changzhou Qianhong BiopharmaLTD's (SZSE:002550) Earnings Quality
May 02Does Changzhou Qianhong BiopharmaLTD (SZSE:002550) Have A Healthy Balance Sheet?
Mar 24Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 002550's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥177.0M).
Uzun Vadeli Yükümlülükler: 002550's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥94.4M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 002550 has more cash than its total debt.
Borcun Azaltılması: 002550's debt to equity ratio has reduced from 18.2% to 0.9% over the past 5 years.
Borç Kapsamı: 002550's debt is well covered by operating cash flow (3233.8%).
Faiz Kapsamı: 002550 earns more interest than it pays, so coverage of interest payments is not a concern.